Blog
RSS FeedPosted by Michael Wonder on 22 Aug 2016
FDA approves Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) extended-release capsules CII with abuse-deterrent properties for the management of pain
19 August 2016 - Pfizer announced today that the U.S. FDA has approved Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) extended-release ...